There's no single answer. Here's how to find yours.
When I first started managing medical device procurement for a mid-sized hospital group, I assumed the lowest quote was always the right answer. That's what the spreadsheet said, and I trusted spreadsheets. Three years and several expensive lessons later, I realized the math was incomplete.
Look, I'm not here to tell you that premium pricing is always justified. That'd be ridiculous. But I've audited $180,000 in cumulative procurement spend across 6 years, and I've found a pattern: in certain situations, paying for reliability isn't an expense. It's an investment. Specifically, an investment in time certainty.
So let's break this down by scenario. Which situation describes you right now?
Scenario A: The baseline restock
You're ordering shelf-stable supplies — think standard Mölnlycke Barrier surgical drapes in common sizes, or Biogel gloves in the most-used hand sizes. You have a 3-4 week buffer, the order is predictable, and you're not under any unusual deadline pressure.
The playbook: Go for cost efficiency. Run a competitive quote against 2-3 authorized distributors. Watch out for hidden costs — I've seen a “$300 lower” quote end up $450 higher when you add expedited shipping fees that the low-priced vendor didn't disclose upfront. In January 2024, I almost signed a deal for Mölnlycke Mepilex dressings with a new distributor that was $0.18 per unit cheaper. What they didn't mention: they required a minimum order of 10,000 units to hit that price, and we only needed 4,000. The “discount” would have locked up inventory budget for 3 extra months. We stuck with our existing distributor at the slightly higher unit price. That decision saved us about $1,200 in unnecessary inventory costs over the next quarter.
The bottom line: For routine, predictable orders, play the price game. Just make sure you're comparing apples to apples on the full cost picture.
Scenario B: The urgent clinical need
This is where my thinking changed completely. In Q3 2023, we had a sudden spike in complex wound cases following a series of emergency surgeries. Our standard Mölnlycke Mepilex Border stock was gone, and we needed a specific size — 7.9” x 7.9” — that was backordered with our usual distributor. The alternative was using a different dressing that the clinical team was less comfortable with.
I called a second distributor who had it in stock. The price was 22% higher per unit. Plus $75 for next-day air shipping. Total premium: roughly $400 on the order. My first instinct was to push back. I almost did.
Then I had the right question: what's the cost of using a dressing the clinical team is uncertain about? What if a dressing change fails? What if a patient's recovery is delayed? I can't quantify that perfectly. But I can tell you this: the $400 I almost argued about was less than 0.3% of our quarterly wound care budget. The decision felt obvious after that framing.
The lesson: In urgent clinical situations, the “cheap” option isn't the one with the lower unit price. The cheap option is the one that works reliably and gets used correctly by staff. The premium is buying certainty — that the product works as expected, that the team trusts it, that you don't have to deal with a clinical incident review later.
Since then, I've built a rule: for any urgent order where the clinical impact of getting it wrong is significant, I budget up to 30% premium for known, trusted supplies. That's a guideline, not a rule. It depends on the specifics. But it changed how I think about “cost.”
Scenario C: The regulatory or accreditation deadline
This one doesn't involve patient care directly but can be just as expensive to mess up. In 2024, we had a compliance audit coming up, and we needed to update our infection control protocols, which required a specific type of Mölnlycke product that had been recently recommended by a standards body. We were 45 days out from the audit.
The product was available from two distributors. One was about 15% cheaper but projected 6-8 weeks for delivery. The other was more expensive but could guarantee delivery within 3 weeks, with a penalty clause on their side if they missed it. I recommended the second option. The procurement director pushed back. I showed him the calculation: the cost of the compliance failure — potential citations, follow-up audits, reputational damage — was far larger than the $600 premium. We went with the more expensive distributor. The product arrived in 17 days. The audit passed without a finding related to that item.
Key takeaway: When the consequence of delay is a compliance or regulatory failure, the premium for delivery certainty is almost always justified. The worst case isn't that you paid more. The worst case is that the cheap option doesn't arrive in time and you fail the audit. That's a risk that doesn't show up on the purchase order.
How to decide which scenario you're in
I get it — it's not always clear. Here's the framework I use now (it's not rocket science, but it works):
Ask yourself three questions:
- What's the cost of delay? If the product doesn't arrive on time, what happens? A patient being on a less-than-ideal dressing for two extra days? A surgery being postponed? An auditor writing up a finding? The more concrete that cost is, the more sense certainty makes.
- Can you quantify the clinical risk? I'm not asking for a precise dollar figure. I'm asking: is this a supply-chain-only decision, or does it touch patient outcomes? If it touches outcomes, the error costs are usually much higher than the price premium.
- Is the supplier track record solid? I've been burned by “fast and cheap” vendors who couldn't deliver. That's a pattern, not an accident. If a reliable supplier — like Mölnlycke through a strong distributor — can deliver with certainty, that's worth something. If a cheaper, less reliable supplier says they can match the delivery, I discount their promise. In my experience, about 30% of those promises fall through.
There's something satisfying about a procurement process where you don't have to worry about the delivery. After all the stress of urgent orders and compliance deadlines, seeing the supplies arrive on time, correct, and used effectively by the team — that's the payoff. It's not always the cheapest path. But it's often the smartest one.
Pricing and timelines mentioned are based on my procurement history between Q3 2023 and Q4 2024. Actual rates, availability, and delivery times vary by location, distributor, and time of order. Always verify current pricing and delivery commitments directly.
